Real Answers.
Better Outcomes Through Focused Intervention Research and clinical best practice support delivering therapy in focused episodes of care rather than ongoing low-frequency treatment over extended periods of time. Our new model provides: 1-2 therapy session per week depending on the... Read More: Understanding Our New Pediatric Therapy Episodic Care Model
MARSHALL, Mich. — Oaklawn is pleased to announce the appointment of David A. Swender, D.O., as Chief Medical Officer (CMO), effective September 1, 2026. Dr. Swender, a board-certified allergist and immunologist, has served the Marshall community through Oaklawn Medical Group... Read More: Oaklawn Names Dr. David Swender Chief Medical Officer, Retains Allergy, Asthma & Immunology Services
MARSHALL, Mich. — The Oaklawn Board of Directors has announced that Dr. J. Summer Liston-Crandall, MD, MBA, FACHE, has been appointed President and Chief Executive Officer of Oaklawn, effective September 1, 2026. Dr. Liston-Crandall will succeed Gregg Beeg, who will... Read More: Oaklawn Announces Planned Leadership Transition; Dr. Summer Liston-Crandall Named Next President & CEO
